Jennifer Naylor

Jennifer Naylor

Corporate Officer/Principal at Thirty-5 Capital

Health Technology
Consumer Services
Finance

Profile

Jennifer Naylor is the Chief Commercial Officer at Thirty-5 Capital.
In this role, she is responsible for business development, marketing and sales of Thrity-5 Capital and its subsidiaries.
Jennifer has over 20 years of experience of developing strategic plans and executing strategy to achieve company growth targets.
Previously, Jennifer worked at Cantel Medical as a Senior Vice President and Hu-Friedy Manufacturing as the Chief Commercial Officer and Executive Vice President.
She spearheaded strategy development that drove new product innovation, education and marketing initiatives.
She served on the OSAP Board and Foundation Board and was named one of the Top 25 Women in dentistry and was named one of Crain’s 2020 Notable Women in Manufacturing.
Jennifer received her Bachelor of Science in Biology from the University of Illinois Urbana-Champaign and a Masters of Business Administration from DePaul University Charles H.
Kellstadt Graduate School of Business.

Jennifer Naylor active positions

CompaniesPositionStart
Corporate Officer/Principal 2021-12-31
All active positions of Jennifer Naylor

Former positions of Jennifer Naylor

CompaniesPositionEnd
CANTEL MEDICAL CORP. Corporate Officer/Principal 2021-07-31
Corporate Officer/Principal 2021-07-31
See the detail of Jennifer Naylor's experience

Training of Jennifer Naylor

DePaul University Masters Business Admin
University of Illinois At Urbana–Champaign Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jennifer Naylor's experience

Connections

100 +

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies3

Health Technology

Health Technology

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Jennifer Naylor
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW